Literature DB >> 24708542

Impaired copper and iron metabolism in blood cells and muscles of patients affected by copper deficiency myeloneuropathy.

Marco Spinazzi1, Angelo Sghirlanzoni, Leonardo Salviati, Corrado Angelini.   

Abstract

AIMS: Severe copper deficiency leads in humans to a treatable multisystem disease characterized by anaemia and degeneration of spinal cord and nerves, but its mechanisms have not been investigated. We tested whether copper deficit leads to alterations in fundamental copper-dependent proteins and in iron metabolism in blood and muscles of patients affected by copper deficiency myeloneuropathy, and if these metabolic abnormalities are associated with compensatory mechanisms for copper maintenance.
METHODS: We evaluated the expression of critical copper enzymes, of iron-related proteins, and copper chaperones and transporters in blood and muscles from five copper-deficient patients presenting with subacute sensory ataxia, muscle paralysis, liver steatosis and variable anaemia. Severe copper deficiency was caused by chronic zinc intoxication in all of the patients, with an additional history of gastrectomy in two cases.
RESULTS: The antioxidant enzyme SOD1 and subunit 2 of cytochrome c oxidase were significantly decreased in blood cells and in muscles of copper-deficient patients compared with controls. In muscle, the iron storage protein ferritin was dramatically reduced despite normal serum ferritin, and the expression of the haem-proteins cytochrome c and myoglobin was impaired. Muscle expression of the copper transporter CTR1 and of the copper chaperone CCS, was strikingly increased, while antioxidant protein 1 was diminished.
CONCLUSIONS: copper-dependent enzymes with critical functions in antioxidant defences, in mitochondrial energy production, and in iron metabolism are affected in blood and muscles of patients with profound copper deficiency leading to myeloneuropathy. Homeostatic mechanisms are strongly activated to increase intracellular copper retention.
© 2013 British Neuropathological Society.

Entities:  

Keywords:  ataxia; copper deficiency; iron; myeloneuropathy; spinal cord disease; zinc

Mesh:

Substances:

Year:  2014        PMID: 24708542     DOI: 10.1111/nan.12111

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  5 in total

1.  Mitochondrial Cytochrome c Oxidase Defects Alter Cellular Homeostasis of Transition Metals.

Authors:  Michele Brischigliaro; Denis Badocco; Rodolfo Costa; Carlo Viscomi; Massimo Zeviani; Paolo Pastore; Erika Fernández-Vizarra
Journal:  Front Cell Dev Biol       Date:  2022-05-19

2.  CRISP-R/Cas9 Mediated Deletion of Copper Transport Genes CTR1 and DMT1 in NSCLC Cell Line H1299. Biological and Pharmacological Consequences.

Authors:  Ekaterina Y Ilyechova; Elisa Bonaldi; Iurii A Orlov; Ekaterina A Skomorokhova; Ludmila V Puchkova; Massimo Broggini
Journal:  Cells       Date:  2019-04-06       Impact factor: 6.600

3.  Integrating transcriptome-wide study and mRNA expression profiles yields novel insights into the biological mechanism of chondropathies.

Authors:  Ping Li; Yujie Ning; Xiong Guo; Yan Wen; Bolun Cheng; Mei Ma; Lu Zhang; Shiqiang Cheng; Sen Wang; Feng Zhang
Journal:  Arthritis Res Ther       Date:  2019-08-27       Impact factor: 5.156

4.  Assessing contribution of bottled water in nutrient absorption using the bottled water nutritional quality index (BWNQI) in Iran.

Authors:  Masoomeh Askari; Reza Saeedi; Ramin Nabizadeh; Ahmad Zarei; Maryam Ghani; Marzieh Ehsani; Mahmood Alimohammadi; Mehrnoosh Abtahi
Journal:  Sci Rep       Date:  2021-12-21       Impact factor: 4.379

5.  Augmented mitochondrial cytochrome c oxidase activity in children with iron deficiency: a tandem between iron and copper?

Authors:  Aysenur Bahadir; Erol Erduran; Orhan Değer; Yelda Birinci; Ahmet Ayar
Journal:  Arch Med Sci       Date:  2016-04-27       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.